Argenx shares rank No. 49 on the IBD 50 list of elite growth stocks. The stock has a strong IBD Digital Composite Rating of 98. The 1-99 score measures a stock's fundamental and technical metrics, pitting them against all other stocks. TRENDING: You Don't Have To Dig Far To Cash In On Rare Earths Insmed (INSM) stock catapulted higher while shares of Argenx (ARGX) creeped up Thursday after the top- rated biotech duo beat third-quarter expectations. Argenx, known for its blockbuster immunological-focused drug ...